Skip to main content
SBFM
NASDAQ Life Sciences

Sunshine Biopharma Wins Canadian Approval for Enalapril, Shipping by Year-End

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.16
Mkt Cap
$4.343M
52W Low
$1.03
52W High
$24.3
52W Position info
13% above low
Off High info
95% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

SBFM is trading near its 52-week low of $1.03 (13% above the low) on light trading volume (0.1× avg).

Summary

Sunshine Biopharma received Canadian regulatory approval for Enalapril, a generic cardiovascular drug. The company expects to begin shipping to Canadian pharmacies by year-end 2026. This is a new market entry for the company, which has been focused on the U.S. market. The approval adds a revenue stream, though the company's market cap is small and it faces significant dilution risk from recent ATM sales and warrant adjustments. The timeline shows a pattern of dilutive financing and warrant repricing, so this approval is a positive operational development but must be weighed against the company's financial fragility.

At the time of this announcement, SBFM was trading at $1.16 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.3M. The 52-week trading range was $1.03 to $24.30. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

SBFM - Latest Insights

SBFM
Nov 12, 2026, 11:56 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $2.70
Real-time Price: $2.65 info
Change: -$0.050 (-2%) info
Market Cap: $2.224M info
SBFM
Nov 12, 2026, 4:31 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $2.65 info
Change: -$0.160 (-6%) info
Market Cap: $2.224M info
SBFM
Nov 12, 2026, 4:05 PM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $2.80
Real-time Price: $2.65 info
Change: -$0.150 (-5%) info
Market Cap: $2.224M info
SBFM
Oct 22, 2026, 9:25 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $0.1638
Real-time Price: $2.65 info
Change: Reverse Stock Split info
Market Cap: $2.224M info
SBFM
Oct 14, 2026, 5:21 PM EDT
Filing Type: PRE 14C
Importance Score:
8
Price at Filing: $0.232
Real-time Price: $2.65 info
Change: Reverse Stock Split info
Market Cap: $2.224M info